Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study
Background Natriuretic peptides promote natriuresis, diuresis, and vasodilation. Experimental deficiency of natriuretic peptides leads to hypertension (HTN) and cardiac hypertrophy, conditions more common among African Americans. Hospital‐based studies suggest that African Americans may have reduced...
Main Authors: | Deepak K. Gupta, Brian Claggett, Quinn Wells, Susan Cheng, Man Li, Nisa Maruthur, Elizabeth Selvin, Josef Coresh, Suma Konety, Kenneth R. Butler, Thomas Mosley, Eric Boerwinkle, Ron Hoogeveen, Christie M. Ballantyne, Scott D. Solomon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-05-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://doi.org/10.1161/JAHA.115.001831 |
Similar Items
-
Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study
by: Lena Mathews, et al.
Published: (2020-03-01) -
An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
by: Sara B. Seidelmann, et al.
Published: (2017-04-01) -
Physiology and clinical significance of natriuretic hormones
by: Sandeep Chopra, et al.
Published: (2013-01-01) -
Natriuretic peptides and their usefulness in clinical practise
by: Aleksandra Skałecka, et al.
Published: (2020-09-01) -
Natriuretic peptides: Diagnostic and therapeutic use
by: Kaushik Pandit, et al.
Published: (2011-01-01)